Author Archives: Alberto Molano, PhD

Azithromycin May Reduce Treatment Failure After COPD Exacerbations

Azithromycin treatment initiated during hospitalization for an acute exacerbation of chronic obstructive pulmonary disease (COPD), followed by three months of a low-maintenance dose, seems to reduce treatment failure. The results were reported in “Azithromycin during Acute COPD Exacerbations Requiring Hospitalization (BACE): a Multicentre, Randomized, Double-blind, Placebo-controlled Trial,” published in…

Carrot Rewards Wellness App Launches COPD Campaign

Canadian wellness app Carrot Rewards has announced a new campaign in collaboration with The Lung Association — Ontario and Boehringer Ingelheim (Canada) to reach chronic obstructive pulmonary disease (COPD) patients and educate users about the disease. Carrot Rewards is an artificial intelligence-driven wellness app and brand engagement…

Novel Non-invasive Imaging Technique May Help Detect Lung Changes Earlier in COPD Patients, Study Says

A relatively new non-invasive imaging technique, called parametric response mapping (PRM), can identify damage in the smallest airways, opening the possibility of detecting specific lung changes earlier (when it is most treatable) in patients with chronic obstructive pulmonary disease (COPD), and allowing doctors to more accurately measure the response…